Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 10
2003 1
2004 9
2005 8
2006 8
2007 5
2008 6
2009 8
2010 10
2011 22
2012 19
2013 14
2014 19
2015 15
2016 16
2017 15
2018 8
2019 16
2020 19
2021 23
2022 25
2023 18
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

265 results

Results by year

Filters applied: . Clear all
Page 1
Serum Lipid Profiles, Blood Glucose, and High-Sensitivity C-Reactive Protein Levels Among People Living with HIV Taking Dolutegravir and Ritonavir-Boosted Atazanavir-Based Antiretroviral Therapy at Jimma University Medical Center, Southwest Ethiopia, 2021.
Waritu NC, Nair SKP, Birhan B, Adugna T, Awgichew GB, Jemal M. Waritu NC, et al. Among authors: nair skp. HIV AIDS (Auckl). 2024 Feb 12;16:17-32. doi: 10.2147/HIV.S430310. eCollection 2024. HIV AIDS (Auckl). 2024. PMID: 38369986 Free PMC article.
A cyclophosphamide-induced immunosuppression Swiss Albino mouse model unveils a potential role for cow urine distillate as a feed additive.
Kolathingal-Thodika N, Usha PTA, Sujarani S, Suresh NN, Priya PM, Naseef PP, Kuruniyan MS, Ollakkode S, Elayadeth-Meethal M. Kolathingal-Thodika N, et al. Among authors: suresh nn. J Ayurveda Integr Med. 2023 Sep-Oct;14(5):100784. doi: 10.1016/j.jaim.2023.100784. Epub 2023 Aug 21. J Ayurveda Integr Med. 2023. PMID: 37611511 Free PMC article.
Validation of Immunotherapy Response Score as Predictive of Pan-solid Tumor Anti-PD-1/PD-L1 Benefit.
Bulen BJ, Khazanov NA, Hovelson DH, Lamb LE, Matrana M, Burkard ME, Yang ES, Edenfield WJ, Claire Dees E, Onitilo AA, Buchschacher GL, Miller AM, Parsons BM, Wassenaar TR, Suga JM, Siegel RD, Irvin W, Nair S, Slim JN, Misleh J, Khatri J, Masters GA, Thomas S, Safa MM, Anderson DM, Mowers J, Dusenbery AC, Drewery S, Plouffe K, Reeder T, Vakil H, Patrias L, Falzetta A, Hamilton R, Kwiatkowski K, Johnson DB, Rhodes DR, Tomlins SA. Bulen BJ, et al. Among authors: nair s. Cancer Res Commun. 2023 Jul 25;3(7):1335-1349. doi: 10.1158/2767-9764.CRC-23-0036. eCollection 2023 Jul. Cancer Res Commun. 2023. PMID: 37497337 Free PMC article.
265 results